How often do you expect NMPA to require the periodic required clinical evaluations (e.g. 1x/year, 1x/5 years)?

As discussed, this is not clarified in the current technical guidance. We believe, however, the updating frequency may be similar to that of EU CERs. This is something we are hypothesizing. Stay tuned for the upcoming final released guidance. It may contain some interpretations or clarifications on this regard.

Suggested Reading

Whether a similar device can be chosen as a control product in a parallel controlled clinical trial?
What are the principles for selecting devices for control group in parallel controlled clinical trials?
Whether overseas clinical trial data only can be accepted when Chinese subjects were enrolled?
Whether the documents of comparable medical device(s) must be authorized by its administrative counterpart?
Does the approval of the clinical trial application also approve the clinical trial plan?
How do I prepare a PDF version of the registration application?
Whether all the comparing items listed in the “Guidelines for Clinical Evaluation of Medical Devices” need to be…
Whether medical devices listed in “The Catalog of Class III Medical Devices that Needs Approval for Clinical…
Whether the overseas clinical trial data must meet the requirements of the Chinese guidelines of specific products?
What clinical data sources can be used except the source from literature of comparable medical devices?
How to understand the suggestions about font size in the materials in the “Technical Guide for Electronic…
After the eRPS system is launched, how can I submit supplementary materials for registration and declaration…

How Often Do You Expect NMPA To Require The Periodic Required Clinical Evaluations (e.g. 1x/year, 1x/5 Years)?

Suggested Reading